📊 Score Breakdown
Offering Ability
20
Cash Runway
85
Float Risk
35
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
54%
🔄 Reverse Split
70%
• 50-day avg $0.11 below $1 exchange minimum
• Only 4 months cash — financial pressure
📉 Score Deterioration
40%
• Score rose 27 points recently (worsening)
💰 Capital Raise
35%
• Low cash runway: 4 months remaining
💹 Market Data
Market Cap$8.15M
Shares Outstanding101.82M
Float53.32M
Cash$81.5K
Debt$2.64M
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest1.2K
Days to Cover1.0
% of FloatN/A
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Jan 31, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for HNOI
📊 HNOI FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 HNOI Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.